Effect of anionic surfactants on grafting density of gelatin modified with PDMS-E

Preparation of Gelatin-Quaternary Ammonium Salt Coating on Titanium Surface for Antibacterial/Osteogenic Properties

Titanium (Ti) and its alloys are widely used in medical treatment, engineering, and other fields because of their excellent properties including biological activity, an elastic modulus similar to that of human bones, and corrosion resistance. However, there are still many defects in the surface properties of Ti in practical applications. For example, the biocompatibility of Ti with bone tissue can be greatly reduced in implants due to a lack of osseointegration as well as antibacterial properties, which may lead to osseointegration failure. To address these problems and to take advantage of the amphoteric polyelectrolyte properties of gelatin, a thin layer of gelatin was prepared by electrostatic self-assembly technology. Diepoxide quaternary ammonium salt (DEQAS) and maleopimaric acid quaternary ammonium salt (MPA-N⁺) were then synthesized and grafted onto the thin layer. The cell adhesion and migration experiments demonstrated that the coating has excellent biocompatibility, and those grafted with MPA-N⁺ promoted cell migration. The bacteriostatic experiment showed that the mixed grafting with two ammonium salts had excellent bacteriostatic performance against Escherichia coli and Staphylococcus aureus, with bacteriostasis rates of 98.1 ± 1.0% and 99.2 ± 0.5%, respectively.

Influence of a Composite Polylysine-Polydopamine-Quaternary Ammonium Salt Coating on Titanium on Its Ostogenic and Antibacterial Performance

Thin oxide layers form easily on the surfaces of titanium (Ti) components, with thicknesses of <100 nm. These layers have excellent corrosion resistance and good biocompatibility. Ti is susceptible to bacterial development on its surface when used as an implant material, which reduces the biocompatibility between the implant and the bone tissue, resulting in reduced osseointegration. In the present study, Ti specimens were surface-negatively ionized using a hot alkali activation method, after which polylysine and polydopamine layers were deposited on them using a layer-by-layer self-assembly method, then a quaternary ammonium salt (QAS) (EPTAC, DEQAS, MPA-N⁺) was grafted onto the surface of the coating. In all, 17 such composite coatings were prepared. Against Escherichia coli and Staphylococcus aureus, the bacteriostatic rates of the coated specimens were 97.6 ± 2.0% and 98.4 ± 1.0%, respectively. Thus, this composite coating has the potential to increase the osseointegration and antibacterial performance of implantable Ti devices.

Adsorption-Reaction Processes Between Gelatin and PDMS-E Emulsion Droplets

In this work, the effects of droplet size and reaction time on the adsorption-reaction processes between gelatin and α-[3-(2,3-epoxypropoxy) propyl]-ω-butyl-polydimethylsiloxane (PDMS-E) emulsion droplets were studied. Gelatin molecules were only physically adsorbed on the surface of the PDMS-E droplet in the 0-75 min range, which was unrelated to the droplet size (100-1000 nm). For the small-size droplets (<410 nm), the physical adsorption proceeded over 75 min followed by agglomeration. For middle-size droplets (410-680 nm), the physical adsorption finished at 125 min; subsequently, the nucleophilic reaction between the primary amino group and the epoxy group began to happen, and globular-like or core-shell colloidal particles were formed. For large-size droplets (>680 nm), the nucleophilic reaction occurred at 75 min and produced core-shell or multi-layered colloidal particles. In a word, the physical absorption or nucleophilic reaction between gelatin and PDMS-E emulsion droplets could be controlled by controlling the droplet size and reaction time. Furthermore, the soft tissue paper coated with large-size droplets exhibited excellent resistance to water permeability and flame-resistant performance, which were carried out by water resistance and flammability tests.

Preparation of Compositional Gradient Polymeric Films Based on Gradient Mesh Template

In this paper, a template-filling method was found to prepare composition gradient gelatin films by incorporating α-[3-(2,3-epoxypropoxy) propyl]-ω-butyl-polydimethylsiloxane (PDMS⁻E) grafted gelatin (PGG) into a gradient gelatin mesh template. The method can be used to prepare other composition gradient biopolymer films. Gradient mesh template prepared by the methacrylic anhydride cross-linked gelatin under temperature gradient field. The porosity of the template decreased from 89 to 35% which was accompanied by decrease in average pore size from 160 to 50 µm. Colloidal particles about 0.9~10 µm were formed from PGG after adding them to a mixed solvent system of 9:1 (v/v) of ethanol/water, which were filled in the mesh template under vacuum (0.06 MPa). A gradient film was obtained after drying at room temperature for 48 h. The results of scanning electron microscope-energy dispersive X-ray combined with freezing microtome and Fourier transform infrared spectroscopy suggested that the distribution of the Si element along the thickness showed a typical gradient pattern, which led to hydrophilic/hydrophobic continuous changing along the thickness of film. The water vapor permeability, thermal gravimetric analysis, differential scanning calorimetry and dynamic mechanical tensile results show that the gradient films had excellent water vapor permeability and flexibility, and hence could be used as biomimetic materials and leather finishing agents.

In-situ formation of growth-factor-loaded coacervate microparticle-embedded hydrogels for directing encapsulated stem cell fate

The spontaneous formation of coacervate microdroplet-laden photo-crosslinked hydrogels derived from the simple mixing of oxidized, methacrylated alginate (OMA) and methacrylated gelatin (GelMA) enables simultaneous creation of drug-laden microdroplets and encapsulation of stem cells in photopolymerized coacervate hydrogels under physiological conditions. This can be utilized as a novel platform for in situ formation of localized, sustained bioactive molecule delivery to encapsulate stem cells for therapeutic applications.